obesity treatment
9 stories related to this topic, newest first.
The Boston GlobeReader Responses to GLP-1 Weight Loss Drugs and Insurance Coverage Changes
Readers of The Boston Globe have shared varied opinions on GLP-1 medications for obesity treatment following a February 22 article. Some highlight the drugs' benefits for health conditions beyond weight loss, while others question obesity as a disease and oppose insurance subsidi…
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)Study Identifies Genetic Variations Influencing Response to Weight-Loss Drugs Wegovy and Mounjaro
Researchers analyzed genetic data from 15,000 individuals to identify variations linked to weight-loss outcomes and side effects from medications like Wegovy and Mounjaro. The study, published in Nature, found that certain variants affect weight reduction and nausea or vomiting s…
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)Eli Lilly Launches Oral GLP-1 Medication Orforglipron for Weight Loss in the United States
Eli Lilly and Company has introduced Foundayo, the brand name for orforglipron, an oral GLP-1 receptor agonist approved for weight management. The pill offers a non-injectable alternative to existing treatments in the growing obesity drug market. Availability begins in the US, ta…
sciencenews.orgGenomic and Demographic Data Enable Prediction of GLP-1 Drug Weight Loss Response
Researchers have identified that genomic and demographic data can predict the magnitude of weight loss from GLP-1 drugs. This approach involves analysis by 23andMe. The findings focus on drug response and side effects in obesity treatment.
MaxRTXBOSS888 / Wikimedia (CC BY-SA 4.0)Researchers Identify Genetic Variants Linked to Variable Responses to Obesity Drugs
Scientists have identified genetic variants that may explain differences in individual responses to obesity medications. The findings, published in Nature, analyzed data from clinical trials involving drugs like semaglutide. This research highlights the role of genetics in person…
sciencenews.orgGenetic Variants Linked to Weight Loss Outcomes and Side Effects from GLP-1 Drugs
A study published in Nature identifies variations in two genes associated with greater weight loss and increased side effects from GLP-1 receptor agonist drugs like Wegovy and Mounjaro. The research, based on data from 15,000 to nearly 28,000 23andMe users, shows modest genetic i…
neurosciencenews.comGenetic Variants Linked to Weight Loss Outcomes on GLP-1 Drugs in New Study
A study published in Nature identifies variations in two genes associated with greater weight loss and side effects from GLP-1 receptor agonist drugs like Wegovy and Mounjaro. The research, based on data from 15,000 to 28,000 users, shows these genetic factors contribute modestly…
sciencenews.orgGenetic Variations in Two Genes Linked to Weight Loss and Side Effects from GLP-1 Drugs
Research indicates that variations in two genes associated with appetite and digestion can predict greater weight loss in patients using GLP-1 drugs for obesity treatment. These genetic changes also correlate with increased risk of nausea and vomiting as side effects. The finding…
Hunted230 / Wikimedia (CC BY-SA 3.0)First-Time Users of Weight-Loss Medicines Seek Lower Costs and Greater Convenience from Novo Nordisk and Eli Lilly Pills
Seven doctors specializing in obesity report that Americans beginning weight-loss treatments prioritize reduced costs and improved convenience. These patients are evaluating oral medications from Novo Nordisk and Eli Lilly. The preferences reflect ongoing discussions in the obesi…